PMA device
Perclose ProGlide® Suture-Mediated Closure System
Abbott Vascular, Inc. · Device, Hemostasis, Vascular (MGB, Class III) · First FDA decision Oct 9, 2015, newest Dec 9, 2025Vascular access
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
9
Naming "Perclose ProGlide Suture-Mediated"
MAUDE reports
91
Brand "Perclose ProGlide Suture-Mediated", since 2015
PubMed studies
20
Mentioning "Perclose ProGlide Suture-Mediated"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Perclose ProGlide® Suture-Mediated Closure System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- Perclose ProGlide® Suture-Mediated Closure System; Prostar® XL Percutaneous Vascular Surgical SystemPMA supplement
P960043-S127 · Decided Dec 9, 2025 · 211 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, hemostasis, vascular (MGB) · Cardiology
- Perclose ProGlide Suture-Mediated Closure System, Prostar XL Percutaneous Vascular Surgical SystemPMA supplement
P960043-S125 · Decided Mar 9, 2025 · 149 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, hemostasis, vascular (MGB) · Cardiology
- Perclose ProGlide® Suture-Mediated Closure System, Prostar® XL Percutaneous Vascular Surgical SystemPMA supplement
P960043-S124 · Decided Feb 10, 2025 · 157 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, hemostasis, vascular (MGB) · Cardiology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Perclose ProGlide Suture-Mediated", any status and sponsor, newest update first.
- Utility of the Perclose ProGlide™ Suture-Mediated Closure Device After Cardiologic Procedures Via the Femoral Vein Approach (Eight-Clover)Pivotal-lookingEnrolling by invitation
Ewha Womans University Mokdong HospitalAcademic, hospital or other
NCT07827287 · 200 participants (planned) · Start Feb 2, 2026 · Primary completion May 31, 2028
Device: Perclose ProStyle™ Suture-Mediated Closure System · For: Atrial Fibrillation; Atrial Septal Defect; Vascular Closure Device
Sites: Seoul, South Korea
- Suture-Mediated Closure System Following Percutaneous Common Femoral Vein ProceduresPivotal-lookingRecruiting
Suzhou Hengruihongyuan Medical Technology Co. LTDNot on our public-company list
NCT07554976 · 136 participants (planned) · Start Nov 5, 2025 · Primary completion Jun 1, 2026
Device: SPIDER; Perclose ProGlide · For: Percutaneous Intervention Via Common Femoral Vein
Sites: Shanghai, China
- Suture-mediated Closure System Following Endovascular Peripheral Arterial ProceduresPivotal-lookingCompleted
Suzhou Hengruihongyuan Medical Technology Co. LTDNot on our public-company list
NCT05899478 · 135 participants · Start Jun 1, 2023 · Primary completion Jan 1, 2024
Device: Tyknot® Suture-Mediated Closure System; Perclose® ProGlide Suture-Mediated Closure System · For: Percutaneous Intervention Via Femoral Artery
Sites: Hefei, China; Shanghai, China; Hangzhou, China · 5 sites in all
6 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Perclose ProGlide Suture-Mediated", and for the whole product code for context.
This brand
91 reports: 58 malfunction, 30 injury, 1 death
Whole product code MGB
93,533 reports: 17,154 malfunction, 76,023 injury, 315 death
Newest reports for this brand
2024168-2026-04156 · Received Oct 27, 2026 · Event dated Sep 30, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Material Separation
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2024168-2026-04116 · Received Oct 23, 2026 · Event dated Sep 30, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Material Separation
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2024168-2026-04085 · Received Oct 22, 2026 · Event dated Oct 1, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Mechanical Jam
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Perclose ProGlide Suture-Mediated"[tiab]. The summary above synthesizes these.
- Comparison of Figure-of-Eight Suture and Perclose ProGlide Suture-Mediated Closure in Large Bore Venous Access Hemostasis: A Randomized Controlled Trial.
Lodhi H, Shaukat S, Mathews A, et al. · Am J Cardiol · 2023Randomized Controlled Trial
- 24h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: An Indian experience.
Vinayakumar D, Kayakkal S, Rajasekharan S, et al. · Indian Heart J · 2017Observational Study
- Application of Perclose ProGlide closure device in transbrachial endovascular intervention.
Zhao P, Yao Y, Yang Q, et al. · Sci Rep · 2025Research Support, Non-U.S. Gov't
- Ambulatory pulmonary vein isolation workflow using the Perclose ProglideTM suture-mediated vascular closure device: the PRO-PVI study.
Fabbricatore D, Buytaert D, Valeriano C, et al. · Europace · 2023Observational Study
- Novel interventional technique for the treatment of an iatrogenic pseudoaneurysm of the brachial artery.
Inagaki Y, Nakao M, Arashi H, et al. · J Cardiol Cases · 2022Case Reports
- Large-bore arterial access closure after transcatheter aortic valve replacement: a systematic review and network meta-analysis.
Montalto C, Munafò AR, Arzuffi L, et al. · Eur Heart J Open · 2022
- Perclose ProGlide embolization as a complication: case report and review of literature.
Giniyani LL, Rana YP, J Hanumanthu BK, et al. · Future Cardiol · 2021Case Reports, Review
- Preclosure technique versus arterial cutdown after percutaneous cannulation for venoarterial extracorporeal membrane oxygenation.
Chandel A, Desai M, Ryan LP, et al. · JTCVS Tech · 2021
- Single suture-mediated closure system after transfemoral transcatheter aortic valve implantation: A single-center real-world experience.
Iacovelli F, Burattini O, Sturdà F, et al. · Catheter Cardiovasc Interv · 2024Observational Study
- Watchman Device Procedure Complicated by Rare Perclose ProGlide Embolization: Case Report and Literature Review.
Beshai R · Cureus · 2022Case Reports
- Investigating the effects of percutaneous endovascular aneurysm repair for abdominal aortic aneurysm on the lumen size of the common femoral artery.
Ong WWX, Tay HT, Chong TT · CVIR Endovasc · 2024
- [Total percutaneous endovascular abdominal aortic aneurysm repair].
Zhang HP, Guo W, Liu XP, et al. · Zhonghua Wai Ke Za Zhi · 2010Evaluation Study
Other devices of this type
Also filed under product code MGB.
- Angio-Seal Vascular Closure DeviceTerumo Medical Corporation · PMA 2013
- StarClose SE® Vascular Surgical SystemAbbott Vascular Devices · PMA 2025
- Mynx Vascular Closure DeviceCordis US Corporation · PMA 2013
- MANTA Vascular Closure DeviceTeleflex Medical, LLC · PMA 2024
- Vascade Vascular Closure System (VCS)Cardiva Medical, Inc. · PMA 2023
- MynxGrip and Mynx Ace Vascular Closure DeviceCordis US Corporation · PMA 2018
- Vascular Solutions Duett Sealing DeviceVascular Solutions, Inc. · PMA 2010
- Angio-Seal Hemostatic Puncture Closure DeviceTerumo Medical Corporation · PMA 2000
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.